MedTrace Pharma A/S
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) (NCT05134012) | MedTrace Pharma A/S | 2022-05-08 |
Track MedTrace Pharma A/S automatically
Every clearance here is in the API, with alerts when new ones post.